JULIE B HUNDLEY
Allopathic & Osteopathic Physicians|Internal Medicine COLUMBUS, OH NPI 1609089366
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine OH ABBVIE INC. All categories
General Payments — all program years on this page
$1,707.69
- Category: General Payments
- Program years: PY2018–2024
- Record count: 105
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $747.88 across 46 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $747.88 | 46 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $172.37 | 14 |
| Lilly USA, LLC | $59.14 | 3 |
| Amgen Inc. | $58.28 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $52.51 | 3 |
| Novo Nordisk AS | $39.31 | 2 |
| GlaxoSmithKline, LLC. | $39.17 | 2 |
| PFIZER INC. | $34.85 | 2 |
| E.R. Squibb & Sons, L.L.C. | $32.62 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.81 | 2 |
| Ultragenyx Pharmaceutical Inc. | $23.35 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $22.96 | 1 |
| Exact Sciences Corporation | $19.77 | 1 |
| Amneal Pharmaceuticals LLC | $19.51 | 1 |
| Phathom Pharmaceuticals, Inc. | $19.10 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.75 | 1 |
| Merck Sharp & Dohme Corporation | $16.30 | 1 |
| Averitas Pharma Inc. | $15.93 | 1 |
| Bausch Health US, LLC | $15.60 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.40 | 1 |
| Janssen Pharmaceuticals, Inc | $14.79 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.39 | 1 |
| Astellas Pharma US Inc | $13.97 | 1 |
By program year
Records — PY2024 (46)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.